Abstract
The POT family of proton-dependent oligopeptide transporters belongs to the Major Facilitator Superfamily and is widely distributed within prokaryotic and eukaryotic kingdoms. They function as proton:peptide symporters, using the inwardly directed proton electrochemical gradient to drive the uptake of di- and tripeptides into the cell. Mammals contain two members of the POT family, PepT1 and PepT2, which in addition to their physiological role in peptide import also recognise and transport several important drug families, including the β-lactam antibiotics and a growing library of peptide modified pro-drugs. A detailed molecular understanding of peptide recognition and transport within the POT family therefore has an acute medical significance that crystallographic methods are now uniquely placed to address. In the last few years the crystal structures of two prokaryotic POT family transporters have been determined, one with bound ligand. These structures represent key intermediates in the transport cycle and reveal remarkably well-conserved sequence and structural motifs that impact peptide specificity and transport rates. However, key questions remain to be answered, including the site(s) and role of protonation and peptide binding in orchestrating the structural changes that result in transport. In this chapter we discuss the insights recent crystal structures of bacterial POT family transporters have provided and examine how these questions are being addressed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, Iwata S (2003) Structure and mechanism of the lactose permease of Escherichia coli. Science 301(5633):610–615
Anderson CMH, Thwaites DT (2010) Hijacking solute carriers for proton-coupled drug transport. Physiology 25(6):364–377
Bailey P, Boyd C, Bronk J, Collier I, Meredith D, Morgan K, Temple C (2000) How to make drugs orally active: a substrate template for peptide transporter PepT1. Angew Chem Int Ed Engl 39:505–508
Biegel A, Knutter I, Hartrodt B, Gebauer S, Theis S, Luckner P et al (2006) The renal type H+/peptide symporter PEPT2: structure-affinity relationships. Amino Acids 31(2):137–156
Bolger MB, Haworth IS, Yeung AK, Ann D, von Grafenstein H, Hamm-Alvarez S, Okamoto CT, Kim KJ, Basu SK, Wu S, Lee VH (1998) Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1. J Pharm Sci 87:1286–1291
Brandsch M (2009) Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls. Expert Opin Drug Metab Toxicol 5(8):887–905
Brandsch M, Knütter I, Bosse-Doenecke E (2008) Pharmaceutical and pharmacological importance of peptide transporters. J Pharm Pharmacol 60(5):543–585
Casagrande F, Harder D, Schenk A, Meury M, Ucurum Z, Engel A et al (2009) Projection structure of DtpD (YbgH), a prokaryotic member of the peptide transporter family. J Mol Biol 394(4):708–717
Chen X-Z, Zhu T, Smith DE, Hediger MA (1999) Stoichiometry and kinetics of the high-affinity H+-coupled peptide transporter PepT2. J Biol Chem 274(5):2773–2779
Chen XZ, Steel A, Hediger MA (2000) Functional roles of histidine and tyrosine residues in the H(+)-peptide transporter PepT1. Biochem Biophys Res Commun 272(3):726–730
Chiang C-S, Stacey G, Tsay Y-F (2004) Mechanisms and functional properties of two peptide transporters, AtPTR2 and fPTR2. J Biol Chem 279(29):30150–30157
Covitz KM, Amidon GL, Sadée W (1998) Membrane topology of the human dipeptide transporter, hPEPT1, determined by epitope insertions. Biochemistry 37(43):15214–15221
Dang S, Sun L, Huang Y, Lu F, Liu Y, Gong H et al (2010) Structure of a fucose transporter in an outward-open conformation. Nature 467(7316):734–738
Daniel H, Kottra G (2004) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch 447(5):610–618
Daniel H, Rubio-Aliaga I (2003) An update on renal peptide transporters. Am J Physiol Renal Physiol 284(5):F885–F892
Daniel H, Spanier B, Kottra G, Weitz D (2006) From bacteria to man: archaic proton-dependent peptide transporters at work. Physiology 21:93–102
Döring F, Dorn D, Bachfischer U, Amasheh S, Herget M, Daniel H (1996) Functional analysis of a chimeric mammalian peptide transporter derived from the intestinal and renal isoforms. J Physiol (Lond) 497(Pt 3):773–779
Ernst HA, Pham A, Hald H, Kastrup JS, Rahman M, Mirza O (2009) Ligand binding analyses of the putative peptide transporter YjdL from E. coli display a significant selectivity towards dipeptides. Biochem Biophys Res Commun 389(1):112–116
Fang G, Konings WN, Poolman B (2000) Kinetics and substrate specificity of membrane-reconstituted peptide transporter DtpT of Lactococcus lactis. J Bacteriol 182(9):2530–2535
Fei YJ, Kanai Y, Nussberger S, Ganapathy V, Leibach FH, Romero MF et al (1994) Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature 368(6471):563–566
Fei YJ, Liu W, Prasad PD, Kekuda R, Oblak TG, Ganapathy V et al (1997) Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2. Biochemistry 36(2):452–460
Forrest LR, Krämer R, Ziegler C (2011) The structural basis of secondary active transport mechanisms. Biochim Biophys Acta 1807(2):167–188
Hauser M, Kauffman S, Naider F, Becker JM (2005) Substrate preference is altered by mutations in the fifth transmembrane domain of Ptr2p, the di/tri-peptide transporter of Saccharomyces cerevisiae. Mol Membr Biol 22(3):215–227
Hirai T, Heymann JAW, Shi D, Sarker R, Maloney PC, Subramaniam S (2002) Three-dimensional structure of a bacterial oxalate transporter. Nat Struct Biol 9(8):597–600
Huang Y, Lemieux MJ, Song J, Auer M, Wang D-N (2003) Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli. Science 301(5633):616–620
Jardetzky O (1966) Simple allosteric model for membrane pumps. Nature 211(5052):969–970
Jensen JM, Ismat F, Szakonyi G, Rahman M, Mirza O (2012) Probing the putative active site of YjdL: an unusual proton-coupled oligopeptide Transporter from E. coli. PLoS ONE 7(10):e47780
Knütter I, Hartrodt B, Theis S, Foltz M, Rastetter M, Daniel H et al (2004) Analysis of the transport properties of side chain modified dipeptides at the mammalian peptide transporter PEPT1. Eur J Pharm Sci 21(1):61–67
Kottra G, Stamfort A, Daniel H (2002) PEPT1 as a paradigm for membrane carriers that mediate electrogenic bidirectional transport of anionic, cationic, and neutral substrates. J Biol Chem 277(36):32683–32691
Kunji E, Michel H, Neutze R, Newstead S (2011) Overcoming barriers to membrane protein structure determination. Nat Biotechnol 29(4):335–340
Law CJ, Maloney PC, Wang D-N (2008) Ins and outs of major facilitator superfamily antiporters. Annu Rev Microbiol 62:289–305
Leibach FH, Ganapathy V (1996) Peptide transporters in the intestine and the kidney. Annu Rev Nutr 16:99–119
Lemieux MJ, Huang Y, Wang D-N (2004) Glycerol-3-phosphate transporter of Escherichia coli: structure, function and regulation. Res Microbiol 155(8):623–629
Liang R, Fei YJ, Prasad PD, Ramamoorthy S, Han H, Yang-Feng TL et al (1995) Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem 270(12):6456–6463
Luckner P, Brandsch M (2005) Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1. Eur J Pharm Biopharm 59(1):17–24
Matthews DM (1975) Intestinal absorption of peptides. Physiol Rev 55(4):537–608
Matthews DM (1991) Protein absorption: development and present state of the subject. Wiley-Liss, New York
Mchaourab HS, Steed PR, Kazmier K (2011) Toward the fourth dimension of membrane protein structure: insight into dynamics from spin-labeling EPR spectroscopy. Structure 19(11):1549–1561
Meredith D, Boyd CA (2000) Structure and function of eukaryotic peptide transporters. Cell Mol Life Sci 57(5):754–778
Moraes I, Evans G, Sanchez-Weatherby J, Newstead S, Stewart PDS (2013) Membrane protein structure determination – The next generation. Biochim Biophys Acta 1838(1):78–87
Newman MJ, Foster DL, Wilson TH, Kaback HR (1981) Purification and reconstitution of functional lactose carrier from Escherichia coli. J Biol Chem 256(22):11804–11808
Newstead S (2011) Towards a structural understanding of drug and peptide transport within the proton-dependent oligopeptide transporter (POT) family. Biochem Soc Trans 39(5):1353–1358
Newstead S, Drew D, Cameron AD, Postis VLG, Xia X, Fowler PW et al (2011) Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2. EMBO J 30(2):417–426
Nicholls DG, Ferguson SJ, Ferguson S (2002) Bioenergetics. Academic, London
Pao SS, Paulsen IT, Saier MH (1998) Major facilitator superfamily. Microbiol Mol Biol Rev 62(1):1–34
Paulsen IT, Skurray RA (1994) The POT family of transport proteins. Trends Biochem Sci 19(10):404
Pieri M, Gan C, Bailey P, Meredith D (2009) The transmembrane tyrosines Y56, Y91 and Y167 play important roles in determining the affinity and transport rate of the rabbit proton-coupled peptide transporter PepT1. Int J Biochem Cell Biol 41(11):2204–2213
Radestock S, Forrest LR (2011) The alternating-access mechanism of MFS transporters arises from inverted-topology repeats. J Mol Biol 407(5):698–715
Rautio J, Kumpulainen H, Heimbach T, Oliyai R, Oh D, Järvinen T et al (2008) Prodrugs: design and clinical applications. Nat Rev Drug Discov 7(3):255–270
Smith DE, Clémençon B, Hediger MA (2013) Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Aspects Med 34(2–3):323–336
Solcan N, Kwok J, Fowler PW, Cameron AD, Drew D, Iwata S et al (2012) Alternating access mechanism in the POT family of oligopeptide transporters. EMBO J 31(16):3411–3421
Sonoda Y, Newstead S, Hu N-J, Alguel Y, Nji E, Beis K et al (2011) Benchmarking membrane protein detergent stability for improving throughput of high-resolution X-ray structures. Structure 19(1):17–25
Steiner H-Y, Naider F, Becker JM (1995) The PTR family: a new group of peptide transporters. Mol Microbiol 16(5):825–834
Steinhardt HJ, Adibi SA (1986) Kinetics and characteristics of absorption from an equimolar mixture of 12 glycyl-dipeptides in human jejunum. Gastroenterology 90(3):577–582
Terada T, Inui K-I (2012) Chapter Eight – recent advances in structural biology of peptide transporters. In: Bevensee MO (ed) Current topics in membranes. Elsevier, Amsterdam, pp 257–274
Terada T, Saito H, Sawada K, Hashimoto Y, Inui K (2000) N-terminal halves of rat H+/peptide transporters are responsible for their substrate recognition. Pharm Res 17(1):15–20
Uchiyama T, Kulkarni AA, Davies DL, Lee VHL (2003) Biophysical evidence for His57 as a proton-binding site in the mammalian intestinal transporter hPepT1. Pharm Res 20(12):1911–1916
Weitz D, Harder D, Casagrande F, Fotiadis D, Obrdlik P, Kelety B et al (2007) Functional and structural characterization of a prokaryotic peptide transporter with features similar to mammalian PEPT1. J Biol Chem 282(5):2832–2839
Xu L, Haworth IS, Kulkarni AA, Bolger MB, Davies DL (2009) Mutagenesis and cysteine scanning of transmembrane domain 10 of the human dipeptide transporter. Pharm Res 26:2358–2366
Yan N (2013) Structural advances for the major facilitator superfamily (MFS) transporters. Trends Biochem Sci 38(3):151–159
Yang B, Smith D (2012) Significance of Peptide Transporter 1 in the intestinal permeability of Valacyclovir in wild-type and PepT1 knockout mice. Drug Metab Dispos 41(3):608–614
Yin Y, He X, Szewczyk P, Nguyen T, Chang G (2006) Structure of the multidrug transporter EmrD from Escherichia coli. Science 312(5774):741–744
Zhao Y, Terry D, Shi L, Weinstein H, Blanchard SC (2010) Single-molecule dynamics of gating in a neurotransmitter transporter homologue. Nature 465(7295):188–193
Zhao Y, Terry DS, Shi L, Quick M, Weinstein H, Blanchard SC et al (2011) Substrate-modulated gating dynamics in a Na + -coupled neurotransmitter transporter homologue. Nature 474(7349):109–113
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Newstead, S. (2014). Alternating Access Within the POT Family of Oligopeptide Proton Symporters. In: Krämer, R., Ziegler, C. (eds) Membrane Transport Mechanism. Springer Series in Biophysics, vol 17. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-53839-1_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-53839-1_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-53838-4
Online ISBN: 978-3-642-53839-1
eBook Packages: Physics and AstronomyPhysics and Astronomy (R0)